You are here: Welcome » pharmaceutical_companies » Qu Biologics

Menu

Rounding The Earth

Operation Uplift

Project List

This is an old revision of the document!

Qu Biologics

Qu Biologics, Inc. is a Canadian biotechnology company based in Burnaby, British Columbia.

History

Qu Biologics was founded in 2007 by Hal Gunn and Rob Freeman.1)

Organization

Qu Biologics is a member organization of the Biotechnology Innovation Organization (BIO) and N2 Canada.2) 3)

Personnel

Qu Biologicals - Team4) 5)
Name Position Notes
Hal Gunn CEO and Founder InspireHealth, University of British Columbia (UBC)
Simon Sutcliffe Chief Medical Officer - Oncology Ontario Cancer Institute, Princess Margaret Hospital, BC Cancer Agency, Canadian Strategy for Cancer Control, Canadian Partnership Against Cancer, Canadian Cancer Society, National Medical Advisory Committee, Michael Smith Foundation for Health Research (MSFHR), Genome British Columbia, International Cancer Control Congress (ICCC), Two Worlds Cancer Collaboration, Premier Diagnostic Centre, Premier Diversified Holdings (PDH), InspireHealth, Institute for Health Systems Transformation & Sustainability (IHSTS), Terry Fox Research Institute (TFRI)
Ted Steiner Chief Medical Officer - Infectious Diseases University of British Columbia, Vancouver General Hospital (VGH), BC Children's Hospital Research Institute, Canadian Institutes of Health Research (CIHR), Crohn's & Colitis Canada, Merck, COVID-19 Immunity Task Force (CITF), Vancouver Coastal Health Research Institute (VCHRI), COVID-19 Clinical Research Coordination Initiative (CRCI)
Matt Cahill Chief Operating Officer Deep Genomics, University of Toronto
Shirin Kalyan Vice President, Scientific Innovation Alexander von Humboldt Foundation, University of British Columbia
David Mullins Chief Scientific Officer (former) Norris Cotton Cancer Center, Society for the Biological Therapy of Cancer, American Association of Immunologists
Gillian Vandermeirsch Vice President of Operations (former) Pasteur Institute, Augurex, University of British Columbia
Bob Cory Vice President of Business Development (former) Bioasis Technologies, Migenix, Illumigen Biosciences
Julie Jang Director of Communications (former) Sirona Biochem, Zalicus, CityNews 1130, Global Television Network, CTV
Heidi Biagi Director of Project Management (former) Novadeq Technologies, QLT
Russell McAllister Vice President of Finance (former) Lakewood-Amedex, H.C. Wainwright & Co., Thomas Weisel Partners, Merriman Curhan Ford & Co., PricewaterhouseCoopers
Jim Pankovich Vice President of Clinical Operations & Drug Development (former) CIHR Canadian HIV Trials Network (CTN), Migenix, Inex Pharmaceuticals, CV Technologies

Funding

Since 2007, Qu Biologics has “raised over CAD$40 million in funding from private investors and government funding”.6)

The company has received grants and investment funding from:7) 8)

1) , 6)
Our History. Qu Biologics Inc. Retrieved May 1, 2023, from http://archive.today/2023.05.01-205011/https://www.qubiologics.com/who-we-are/our-history/
2)
BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory
3)
Members. N2 Canada. Retrieved October 11, 2022, from http://archive.today/2022.10.11-054124/https://n2canada.ca/members/
4)
Management Team. Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502003205/https://www.qubiologics.com/who-we-are/management-team/
5)
Management Team. Qu Biologics. Retrieved February 18, 2015, from http://archive.today/2015.02.18-140801/http://www.qubiologics.com/who-we-are/management-team/
7)
Qu Biologics Inc. - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved May 1, 2023, from https://www.crunchbase.com/organization/qu-biologics-inc/company_financials
8)
Portfolio. ACA Group. Retrieved May 1, 2023, from http://archive.today/2023.05.01-212531/https://aca-investments.com/portfolio/
Back to top